Willow Biosciences Inc. (WLLW.TO)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.18 Million CAD | 26.83% |
| 2022 | -18.39 Million CAD | 21.16% |
| 2021 | -23.33 Million CAD | -1.17% |
| 2020 | -23.06 Million CAD | 50.03% |
| 2019 | -46.14 Million CAD | -2706.03% |
| 2018 | -1.64 Million CAD | -161.52% |
| 2017 | -628.86 Thousand CAD | 28.03% |
| 2016 | -873.73 Thousand CAD | -21.16% |
| 2015 | -721.12 Thousand CAD | 22.11% |
| 2014 | -925.8 Thousand CAD | 10.86% |
| 2013 | -1.03 Million CAD | -65.9% |
| 2012 | -626.07 Thousand CAD | 34.41% |
| 2011 | -954.6 Thousand CAD | 2.67% |
| 2010 | -980.81 Thousand CAD | 52.95% |
| 2009 | -2.08 Million CAD | -98.68% |
| 2008 | -1.04 Million CAD | 49.38% |
| 2007 | -2.07 Million CAD | -392.54% |
| 2006 | -420.82 Thousand CAD | 4.93% |
| 2005 | -442.64 Thousand CAD | -128.57% |
| 2004 | -193.65 Thousand CAD | -7.82% |
| 2003 | -179.61 Thousand CAD | -156.22% |
| 2002 | -70.1 Thousand CAD | 57.74% |
| 2001 | -165.86 Thousand CAD | 7.84% |
| 2000 | -179.96 Thousand CAD | -57.27% |
| 1999 | -114.43 Thousand CAD | 43.38% |
| 1998 | -202.12 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.45 Million CAD | 10.2% |
| 2024 Q2 | -1.44 Million CAD | 40.96% |
| 2023 Q2 | -3.64 Million CAD | 25.66% |
| 2023 Q1 | -4.9 Million CAD | -0.7% |
| 2023 Q4 | -2.73 Million CAD | -22.15% |
| 2023 Q3 | -2.23 Million CAD | 38.61% |
| 2023 FY | -13.45 Million CAD | 26.83% |
| 2022 FY | -18.39 Million CAD | 21.16% |
| 2022 Q2 | -4.5 Million CAD | 7.37% |
| 2022 Q3 | -4.14 Million CAD | 8.09% |
| 2022 Q4 | -4.87 Million CAD | -17.57% |
| 2022 Q1 | -4.86 Million CAD | 25.34% |
| 2021 Q3 | -6.19 Million CAD | -5.99% |
| 2021 FY | -23.33 Million CAD | -1.17% |
| 2021 Q1 | -4.78 Million CAD | 58.46% |
| 2021 Q2 | -5.84 Million CAD | -22.18% |
| 2021 Q4 | -6.52 Million CAD | -5.33% |
| 2020 FY | -23.06 Million CAD | 50.03% |
| 2020 Q1 | -7.03 Million CAD | -127.19% |
| 2020 Q4 | -11.5 Million CAD | -6524.75% |
| 2020 Q2 | 2.09 Million CAD | 129.83% |
| 2020 Q3 | -173.69 Thousand CAD | -108.27% |
| 2019 FY | -46.14 Million CAD | -2706.03% |
| 2019 Q3 | -1.09 Million CAD | 67.99% |
| 2019 Q2 | -3.43 Million CAD | -5720.29% |
| 2019 Q1 | -59 Thousand CAD | 72.09% |
| 2019 Q4 | -3.09 Million CAD | -181.71% |
| 2018 FY | -1.64 Million CAD | -161.52% |
| 2018 Q4 | -211.41 Thousand CAD | 14.48% |
| 2018 Q3 | -247.2 Thousand CAD | -49.46% |
| 2018 Q2 | -165.4 Thousand CAD | -9.72% |
| 2018 Q1 | -150.75 Thousand CAD | 7.12% |
| 2017 Q3 | -150.38 Thousand CAD | 48.7% |
| 2017 Q4 | -162.31 Thousand CAD | -7.93% |
| 2017 FY | -628.86 Thousand CAD | 28.03% |
| 2017 Q1 | -183.73 Thousand CAD | 5.89% |
| 2017 Q2 | -293.17 Thousand CAD | -59.57% |
| 2016 Q2 | -188.26 Thousand CAD | -30.4% |
| 2016 Q3 | -201.59 Thousand CAD | -7.08% |
| 2016 Q4 | -195.22 Thousand CAD | 3.16% |
| 2016 FY | -873.73 Thousand CAD | -21.16% |
| 2016 Q1 | -144.37 Thousand CAD | 30.94% |
| 2015 Q4 | -209.07 Thousand CAD | -19.19% |
| 2015 Q3 | -175.4 Thousand CAD | 20.58% |
| 2015 Q2 | -220.84 Thousand CAD | -17.06% |
| 2015 Q1 | -188.66 Thousand CAD | 1.79% |
| 2015 FY | -721.12 Thousand CAD | 22.11% |
| 2014 Q2 | -296.54 Thousand CAD | -35.19% |
| 2014 FY | -925.8 Thousand CAD | 10.86% |
| 2014 Q1 | -219.35 Thousand CAD | 26.95% |
| 2014 Q4 | -192.1 Thousand CAD | 37.85% |
| 2014 Q3 | -309.07 Thousand CAD | -4.22% |
| 2013 Q4 | -300.27 Thousand CAD | -34.98% |
| 2013 Q2 | -163.73 Thousand CAD | 13.2% |
| 2013 Q3 | -222.46 Thousand CAD | -35.87% |
| 2013 Q1 | -188.62 Thousand CAD | -28.74% |
| 2013 FY | -1.03 Million CAD | -65.9% |
| 2012 Q4 | -146.51 Thousand CAD | -15.17% |
| 2012 FY | -626.07 Thousand CAD | 34.41% |
| 2012 Q3 | -127.21 Thousand CAD | 25.91% |
| 2012 Q2 | -171.7 Thousand CAD | 24.02% |
| 2012 Q1 | -225.96 Thousand CAD | -22.55% |
| 2011 Q3 | -372.55 Thousand CAD | -66.11% |
| 2011 FY | -954.6 Thousand CAD | 2.67% |
| 2011 Q4 | -184.38 Thousand CAD | 50.51% |
| 2011 Q1 | -179.23 Thousand CAD | 35.46% |
| 2011 Q2 | -224.28 Thousand CAD | -25.13% |
| 2010 Q3 | -299.58 Thousand CAD | 19.78% |
| 2010 FY | -980.81 Thousand CAD | 52.95% |
| 2010 Q1 | -238.38 Thousand CAD | 79.46% |
| 2010 Q2 | -373.45 Thousand CAD | -56.66% |
| 2010 Q4 | -277.72 Thousand CAD | 7.3% |
| 2009 Q2 | -186.9 Thousand CAD | 41.34% |
| 2009 Q4 | -1.16 Million CAD | -272.0% |
| 2009 Q1 | -318.61 Thousand CAD | -68.21% |
| 2009 FY | -2.08 Million CAD | -98.68% |
| 2009 Q3 | -311.95 Thousand CAD | -66.9% |
| 2008 FY | -1.04 Million CAD | 49.38% |
| 2008 Q1 | -276.67 Thousand CAD | 27.79% |
| 2008 Q4 | -189.41 Thousand CAD | 46.47% |
| 2008 Q3 | -353.84 Thousand CAD | 70.4% |
| 2008 Q2 | -1.19 Million CAD | -332.09% |
| 2007 Q1 | -56.25 Thousand CAD | 26.89% |
| 2007 FY | -2.07 Million CAD | -392.54% |
| 2007 Q4 | -383.14 Thousand CAD | -76.19% |
| 2007 Q3 | -217.45 Thousand CAD | -4.83% |
| 2007 Q2 | -207.44 Thousand CAD | -268.77% |
| 2006 Q4 | -76.94 Thousand CAD | 4.03% |
| 2006 FY | -420.82 Thousand CAD | 4.93% |
| 2006 Q1 | -117.81 Thousand CAD | -580.13% |
| 2006 Q2 | -280.97 Thousand CAD | -138.5% |
| 2006 Q3 | -80.17 Thousand CAD | 71.46% |
| 2005 FY | -442.64 Thousand CAD | -128.57% |
| 2005 Q1 | 379.09 Thousand CAD | 674.46% |
| 2005 Q2 | -471.61 Thousand CAD | -224.41% |
| 2005 Q3 | -26.53 Thousand CAD | 94.37% |
| 2005 Q4 | -17.32 Thousand CAD | 34.71% |
| 2004 Q3 | -35.14 Thousand CAD | 73.52% |
| 2004 Q4 | -65.99 Thousand CAD | -87.75% |
| 2004 Q2 | -132.71 Thousand CAD | -751.04% |
| 2004 Q1 | -15.59 Thousand CAD | -2.6% |
| 2004 FY | -193.65 Thousand CAD | -7.82% |
| 2003 FY | -179.61 Thousand CAD | -156.22% |
| 2003 Q4 | -15.2 Thousand CAD | 5.6% |
| 2003 Q3 | -16.1 Thousand CAD | 16.66% |
| 2003 Q2 | -19.32 Thousand CAD | 14.24% |
| 2003 Q1 | -22.52 Thousand CAD | 12.53% |
| 2002 Q1 | -35.89 Thousand CAD | 15.08% |
| 2002 FY | -70.1 Thousand CAD | 57.74% |
| 2002 Q2 | -23.59 Thousand CAD | 34.28% |
| 2002 Q4 | -25.75 Thousand CAD | -906.45% |
| 2002 Q3 | -2559.00 CAD | 89.15% |
| 2001 Q2 | -64.91 Thousand CAD | -29.65% |
| 2001 Q3 | -64.1 Thousand CAD | 1.25% |
| 2001 FY | -165.86 Thousand CAD | 7.84% |
| 2001 Q4 | -42.27 Thousand CAD | 34.06% |
| 2001 Q1 | -50.06 Thousand CAD | -46.9% |
| 2000 Q4 | -34.08 Thousand CAD | -10.28% |
| 2000 FY | -179.96 Thousand CAD | -57.27% |
| 2000 Q3 | -30.9 Thousand CAD | 0.0% |
| 1999 FY | -114.43 Thousand CAD | 43.38% |
| 1998 FY | -202.12 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | 71.623% |
| Avicanna Inc. | -7.93 Million CAD | -66.166% |
| Avant Brands Inc. | -1.45 Million CAD | -808.477% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | 55.744% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -573.926% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -356.125% |
| MediPharm Labs Corp. | -18.25 Million CAD | 27.778% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 94.569% |
| Canopy Growth Corporation | -228.71 Million CAD | 94.236% |
| Auxly Cannabis Group Inc. | -19 Million CAD | 30.639% |